Resumen de acción CVS
CVS Health Corporation ofrece soluciones sanitarias en Estados Unidos.
| Puntuación del copo de nieve | |
|---|---|
| Valoración | 5/6 |
| Crecimiento futuro | 1/6 |
| Resultados anteriores | 5/6 |
| Salud financiera | 2/6 |
| Dividendos | 6/6 |
Recompensas
Análisis de riesgos
Community Narratives
Narratives bring a range of perspectives from our community.
WA
WarrenAI
Not InvestedBased on Analyst Price Targets
Decisiveally Navigating Challenges For Enhanced Financial Health And Market Position
US$69.1
FV
15.1% UNDERVALUED4.99%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
2 days agoauthor updated this narrative
JU
julio
Not InvestedCommunity Contributor
CVS VALUATION
US$63.3
FV
7.4% UNDERVALUED9.19%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
17 days agoauthor updated this narrative
Competidores de CVS Health Corporation
Historial de precios y rendimiento
| Precios históricos de las acciones | |
|---|---|
| Precio actual de la acción | US$58.65 |
| Máximo en 52 semanas | US$83.25 |
| Mínimo de 52 semanas | US$52.77 |
| Beta | 0.51 |
| 11 mes Cambio | -2.96% |
| Variación en 3 meses | -12.70% |
| Cambio de 1 año | -22.29% |
| 3Variación en 3 años | -29.39% |
| Variación en 5 años | 5.92% |
| Variación desde la OPV | 8,833.44% |
Noticias y actualizaciones recientes
Here's Why CVS Health (NYSE:CVS) Has A Meaningful Debt Burden
Jul 21
CVS Health: A Better Investment Than Walgreens Boots Alliance
Jul 09Vltava Fund - CVS Health Corp.: Why We Sold CVS
Jul 03CVS Health: Mismanagement, Eroding Moat And Poor Momentum Make It A Sell
Jun 21Recent updates
Here's Why CVS Health (NYSE:CVS) Has A Meaningful Debt Burden
Jul 21CVS Health: A Better Investment Than Walgreens Boots Alliance
Jul 09Vltava Fund - CVS Health Corp.: Why We Sold CVS
Jul 03CVS Health: Mismanagement, Eroding Moat And Poor Momentum Make It A Sell
Jun 21The Correct Play On CVS Health
Jun 06CVS Health: Downside Movement Is Overdramatic
May 26CVS Health: Secure Dividend And Upside Potential Presents Compelling Opportunity
May 15We Think Shareholders Are Less Likely To Approve A Pay Rise For CVS Health Corporation's (NYSE:CVS) CEO For Now
May 10CVS Health: A Terrible Earnings Report, But An Undervalued Stock
May 04CVS Health Corporation Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
May 03CVS Health: 8x P/E, 8% Growth Projection - It's A Market Blind Spot
Apr 22Sentiment Still Eluding CVS Health Corporation (NYSE:CVS)
Apr 14CVS Health: Lookback, Management Guidance Vs. Results 2018-To-Date
Apr 10Does CVS Health (NYSE:CVS) Have A Healthy Balance Sheet?
Mar 27CVS Health: Better Times Likely Ahead
Mar 12CVS Health: Lower Guidance But Risk/Reward Remains Attractive
Feb 15CVS Health FY23 Earnings: Downgrades Inevitable, Long Term Outlook In The Balance
Feb 07CVS Health: Back In The Buy Column
Jan 21CVS Health (NYSE:CVS) Has Announced That It Will Be Increasing Its Dividend To $0.665
Jan 17CVS Health: Shares Remain Modestly Undervalued, Robust Free Cash Flow, Technical Strength
Jan 08CVS Health (NYSE:CVS) Is Paying Out A Larger Dividend Than Last Year
Jan 03CVS Health: Risk/Reward Highly Skewed To The Upside
Dec 15CVS Health (NYSE:CVS) Is Increasing Its Dividend To $0.665
Dec 13We Think CVS Health (NYSE:CVS) Is Taking Some Risk With Its Debt
Dec 08CVS Health: A Good Fit To Buffett's 10x Pretax Rule
Dec 07CVS Health: Not One Dividend Cut In 30 Years And A Good Upside
Nov 27CVS Health: All Eyes On December Investor Day
Nov 21CVS Health Ahead Of Q3 Earnings: Making The Pivot Toward Value-Based Care Work
Oct 26CVS Health: 'Only' A Fair Company For A Wonderful Price?
Oct 20Rentabilidad de los accionistas
| CVS | US Healthcare | Mercado US | |
|---|---|---|---|
| 7D | -2.1% | 0.5% | -2.4% |
| 1Y | -22.3% | 5.7% | 17.5% |
Rentabilidad vs. Industria: Los resultados de CVS fueron inferiores a los de la industria US Healthcare, que obtuvo un rendimiento del 3.5% el año pasado.
Rentabilidad vs. Mercado: CVS obtuvo unos resultados inferiores a los del mercado US, que fueron del 22.3% el año pasado.
Volatilidad de los precios
| CVS volatility | |
|---|---|
| CVS Average Weekly Movement | 6.2% |
| Healthcare Industry Average Movement | 7.1% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 14.9% |
| 10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: CVS no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de CVS (6%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1996 | 259,500 | Karen Lynch | www.cvshealth.com |
CVS Health Corporation ofrece soluciones sanitarias en Estados Unidos. Opera a través de los segmentos Health Care Benefits, Health Services y Pharmacy & Consumer Wellness. El segmento Health Care Benefits ofrece productos de seguro médico tradicionales, voluntarios y dirigidos al consumidor, así como servicios relacionados.
Resumen de fundamentos de CVS Health Corporation
| Estadísticas fundamentales de CVS | |
|---|---|
| Capitalización bursátil | US$73.49b |
| Beneficios(TTM) | US$7.32b |
| Ingresos (TTM) | US$359.66b |
10.1x
Ratio precio-beneficio (PE)0.2x
Ratio precio-ventas (PS)¿Está CVS sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de CVS | |
|---|---|
| Ingresos | US$359.66b |
| Coste de los ingresos | US$307.32b |
| Beneficio bruto | US$52.34b |
| Otros gastos | US$45.02b |
| Beneficios | US$7.32b |
Últimos beneficios comunicados
Mar 31, 2024
Próxima fecha de beneficios
Aug 07, 2024
| Beneficios por acción (BPA) | 5.83 |
| Margen bruto | 14.55% |
| Margen de beneficio neto | 2.04% |
| Ratio deuda/patrimonio | 86.5% |
¿Cómo se ha desempeñado CVS a largo plazo?
Ver rendimiento histórico y comparativa